Isosteviol - Stevia Pharm

Drug Profile

Isosteviol - Stevia Pharm

Latest Information Update: 10 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Stevia Pharm
  • Developer Aarhus Universitetshospital; Stevia Pharm
  • Class Antihyperglycaemics; Diterpenes
  • Mechanism of Action Glucagon receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Type 2 diabetes mellitus

Most Recent Events

  • 18 Oct 2006 Phase-II clinical trials in Type-2 diabetes mellitus in Denmark (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top